Home
About Aglaia
Team
Investments
Careers
Impact / ESG
News
Archive
Contact
Investors login
Menu
Home
About Aglaia
Team
Investments
Careers
Impact / ESG
News
Archive
Contact
Investors login
Menu
News: 2021
Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms
January 06, 2021
• First joint CriVac® vaccine candidate to target receptor-binding domain of SARS-CoV-2 • Evaluation of Cristal's CliCr® and I...
Read more
Previous
1
2
3
Archives
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
News
ISA Pharmaceuticals to present at the ASCO Annual Meeting 2024
April 16, 2024
This abstract describes results of a randomized trial in advanced head and neck cancer with its lead therapeutic vaccine ISA101...
More news
Home
>
News
>
Archive
Contact
Businesspark Berg en Bosch
Prof. Bronkhorstlaan 10, building 92
3723 MB Bilthoven
T +31 (0)30 - 229 60 90
F +31 (0)30 - 229 60 99
info@aglaia-oncology.com
Aglaia Management B.V. is registered with the Trade Register of the Chamber of Commerce and Industry under number 54970857.
© 2024 Aglaia Oncology Funds
|
Privacy
|
Sitemap